Boston Scientific (BSX) EBITDA (2009 - 2026)
Boston Scientific (BSX) posted quarterly EBITDA of $1.2 billion for Q2 2026, up 43.83% year-over-year from $819.0 million in Q2 2025, and up 6.99% on a QoQ basis from $1.1 billion in Q1 2026.
Boston Scientific (BSX) EBITDA (2009 - 2026) Analysis & Trends
Boston Scientific has reported EBITDA for 18 years, with the latest figure at $1.2 billion in Q2 2026.
- EBITDA for Q2 2026 came in at $1.2 billion, up 43.83% year-over-year; the trailing twelve-month figure through Jun 2026 was $4.2 billion (up 31.89% YoY), and the FY2025 annual result was $3.6 billion, up 38.8% from the prior year.
- EBITDA rose to $1.2 billion in Q2 2026, from $1.1 billion in the prior quarter.
- Over five years, EBITDA peaked at $1.2 billion in Q2 2026 and troughed at $358.0 million in Q3 2022.
- A 5-year average of $693.7 million and a median of $675.0 million in 2024 frame the typical range for EBITDA.
- The largest YoY upside for EBITDA was 123.33% in 2022 against a maximum downside of 7.49% in 2022.
- A 5-year view of EBITDA shows it stood at $402.0 million in 2022, then jumped by 45.27% to $584.0 million in 2023, then advanced by 15.58% to $675.0 million in 2024, then climbed by 22.22% to $825.0 million in 2025, then jumped by 42.79% to $1.2 billion in 2026.
- Per Business Quant data, the three most recent EBITDA figures were $1.2 billion in Q2 2026, $1.1 billion in Q1 2026, and $825.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 326.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Bn |
| Mar 31, 2026 | 1.10 Bn |
| Dec 31, 2025 | 825.00 Mn |
| Sep 30, 2025 | 1.05 Bn |
| Jun 30, 2025 | 819.00 Mn |
| Mar 31, 2025 | 921.00 Mn |
| Dec 31, 2024 | 675.00 Mn |
| Sep 30, 2024 | 733.00 Mn |
| Jun 30, 2024 | 520.00 Mn |
| Mar 31, 2024 | 675.00 Mn |
| Dec 31, 2023 | 584.00 Mn |
| Sep 30, 2023 | 693.00 Mn |
| Jun 30, 2023 | 514.00 Mn |
| Mar 31, 2023 | 552.00 Mn |
| Dec 31, 2022 | 402.00 Mn |
| Sep 30, 2022 | 358.00 Mn |
| Jun 30, 2022 | 423.00 Mn |
| Mar 31, 2022 | 466.00 Mn |
| Dec 31, 2021 | 180.00 Mn |
| Sep 30, 2021 | 387.00 Mn |